14 results
·
27ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
MD-2300S Ultrasonic A/B Scanner for Ophthalmology
FDA 510(k)
FDA Class 2
·Radiology
DIVERGENCE-L™ Anterior/Oblique Lumbar Fusion System
FDA UDI
MEDTRONIC SOFAMOR DANEK, INC.·00643169501850·INTERBODY 2152318 LARGE - 12 DEG 18MM
1.5 LACTOSORB SYSTEM
FDA UDI
BIOMET MICROFIXATION, INC·00841036055226·
Varian Cleaning Caps, Varian Leak Stop Buttons, Varian Leak Stop Channel Marker Sets
FDA 510(k)
FDA Class 2
·Radiology
CLEARPATH 24
FDA 510(k)
FDA Class 2
·Gastroenterology, Urology
LACTOSORB TRAUMA PLATING SYSTEM
FDA Adverse Event
Injury
·BIOMET MICROFIXATION·Product code JEY·July 24, 2017
FLOGARD
FDA Adverse Event
Malfunction
·BAXTER HEALTHCARE - SINGAPORE·Product code FRN·June 7, 2013
PUREPOINT
FDA Adverse Event
Malfunction
·ALCON-IRVINE TECHNOLOGY CTR·Product code HQF·October 2, 2014
SYNCHROMED II
FDA Adverse Event
Malfunction
·MDT PUERTO RICO OPERATIONS CO., JUNCOS·Product code LKK·June 23, 2011
ULTRAFLEX DUO HIGH FLUID CART
FDA Adverse Event
Malfunction
·DORNOCH·Product code JCX·August 28, 2017
Integrity 1.1. Integrity is the interface and control software for the Elekta range of medical digital linear accelerators and is intended to assist a licensed practitioner in the delivery of radiation to defined target volumes.
FDA Enforcement
Class II
·Terminated·Elekta, Inc.·April 9, 2014
ELEKTA LIMITED Elekta Synergy, REF MRT 8501, MRT 8511; Medical Charged-Particle Radiation Therapy System Accelerator, Linear
FDA Enforcement
Class II
·Ongoing·Elekta, Inc.·December 13, 2023
OPTETRAK Comprehensive Knee System including OPTETRAK All-polyethylene UNI Tibial Components, Product Lines, 252-12-XX, 252-13-XX, 252-22-XX, 252-23-XX. NOTE: Information reflects Exactech recall expansion initiated on 02/07/2022.
FDA Enforcement
Class II
·Ongoing·Exactech, Inc.·October 13, 2021
CADD-Solis VIP ambulatory Infusion Pumps, Model 2110. Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.
FDA Enforcement
Class I
·Ongoing·Smiths Medical ASD Inc.·August 14, 2024